ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · USD

$1.40

+0.06 (+4.5%)· Recorded snapshot

Market cap	197.6M
Revenue (ttm)	21M
Net income (ttm)	-48M
EPS (ttm)	-$0.46
Shares out	141.1M
Volume	814,104
Beta	0.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21M
Net income (ttm): -48M
EPS (ttm): -$0.46
Market cap: 197.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-57.4

P25 n/aP50 n/aP75 n/a

ROIC-30

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PRQR indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

EUR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001612940
Company name	ProQR Therapeutics N.V.
Country	Netherlands
Country code	US
CUSIP number	N71542109
Earnings date	2026-11-09
Earnings time	bmo
Employees	187
Employees change	21
Employees growth	12.34%
Enterprise value	$81.3M
Exchange	NASDAQ
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Biotechnology
IPO date	2014-09-18
Is primary listing	Yes
Is SPAC	No
ISIN number	NL0010872495
Last 10-K release date	2026-03-12
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$197.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.40
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PRQR
Website	https://www.proqr.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-32.7%
EV/Sales	3.73x
FCF / EV yield	-71.31%
FCF yield	-28.72%
Forward EV/Sales	4.45x
Forward P/S	11.05x
P/B ratio	2.08x
P/S ratio	9.25x
Price / tangible book value	2.14x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-232.6%
EBITDA margin	-227.44%
Gross margin	100%
Operating margin	-232.6%
Pretax margin	-228.04%
Profit margin	-228.18%
Profit per employee	$-257,373
Revenue per employee	$112,796
ROA	-19.76%
ROA (5Y)	-18.09%
ROCE	-43.43%
ROE	-57.4%
ROE (5Y)	-59.64%
ROIC	-29.99%
SBC / revenue	27.86%
Tax / revenue	0.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	7.49%
Gross profit growth (Q)	120.35%
Gross profit growth 3Y	65.84%
Gross profit growth 5Y	60.02%
Net income growth quarters	1
Net income growth years	0
Revenue growth	7.49%
Revenue growth (Q)	120.35%
Revenue growth (QoQ)	330.84%
Revenue growth 10Y	18.48%
Revenue growth 3Y	65.84%
Revenue growth 5Y	60.02%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.3M
Depreciation and amortization	$1.1M
EBIT	$-49M
EBITDA	$-47.9M
EPS	$-0.46
FCF per share	$-0.40
Financing cash flow	$54M
Free cash flow	$-55.9M
Free cash flow minus SBC	$-61.7M
Gross profit	$21M
Income taxes	$29,704
Investing cash flow	$-1.3M
Net borrowing	$-2.2M
Net cash flow	$-3M
Net income	$-48M
Operating cash flow minus SBC	$-60.4M
Operating income	$-49M
Revenue	$21M
Stock-based compensation	$5.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.28
Book value per share	$0.64
Debt / equity	0.19
Interest coverage	-46.13
Long-term assets	$17M
Long-term liabilities	$22.9M
Net cash (debt)	$116.3M
Net cash / market cap	59.73%
Net cash growth	-1.06%
Net debt / equity	-1.28
Piotroski F-Score	1
Property, plant and equipment	$13.3M
Shareholders' equity	$90.8M
Tangible book value	$90.8M
Tangible book value per share	$0.64
Total assets	$152.6M
Total cash	$133.8M
Total debt	$17.5M
Total liabilities	$61.8M
WACC	5.31%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.14
Current assets	$135.6M
Current liabilities	$38.9M
Current ratio	3.49
Net working capital	$-27.1M
Quick ratio	3.41
Working capital	$99.1M
Working capital turnover	0.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.75%
Dividend yield	0%
Shareholder yield	-8.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-77.64%
10Y return CAGR	-13.91%
10Y total return	-77.64%
150-day SMA	$1.72
1D price change	4.48%
1M price change	-16.67%
1M total return	-16.67%
1W price change	-0.36%
1W total return	-0.36%
1Y price change	-51.92%
1Y return CAGR	-51.95%
1Y total return	-51.92%
20-day SMA	$1.47
200-day SMA	$1.69
3M price change	-20.52%
3M total return	-20.52%
3Y price change	17.52%
3Y return CAGR	5.53%
3Y total return	17.52%
50-day SMA	$1.79
50-day SMA vs 200-day SMA	50over200
52-week high	$3.00
52-week high date	2025-10-28
52-week low	$1.20
52-week low date	2026-10-27
5Y price change	-81.72%
5Y return CAGR	-28.81%
5Y total return	-81.72%
6M price change	-7.72%
6M total return	-7.72%
All-time high	$27.60
All-time high date	2015-03-16
All-time low	$0.53
All-time low date	2022-05-11
Average true range (ATR)	$0.09
Average volume	979.4K
Beta (1Y)	2.72
Beta (2Y)	2.16
Beta (5Y)	0.2
Change from 52-week high	-53.33%
Change from 52-week low	16.67%
Change from all-time high	-95.02%
Change from all-time low	159.43%
Change from open	3.7%
Day's gap	0.75%
Dollar volume	$1.1M
High price	$1.40
Low price	$1.32
Monthly RSI	42.95
Open price	$1.35
Position in 52-week range	100%
Premarket change	3.36%
Premarket close	$1.34
Premarket price	$1.39
Premarket volume	100
Previous close	$1.34
Price vs 150-day SMA	-20.24%
Price vs 20-day SMA	-6.4%
Price vs 200-day SMA	-18.83%
Price vs 50-day SMA	-23.14%
Relative volume	0.83
RSI	38.32
Sharpe ratio	-0.67
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.13
Sortino ratio	-0.88
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	0.28
Volume	814.1K
Weekly RSI	39.48
YTD price change	-31.93%
YTD total return	-31.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91.4M
Float percentage	64.8%
Shares change (QoQ)	4.36%
Shares change (YoY)	8.75%
Shares held by insiders	2.08%
Shares held by institutions	37.27%
Shares outstanding	141.1M
Short % of shares	2.67%
Short ratio	4.8 days

Deeper analysis on PRQR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PRQR report

Is a complete PRQR research report available?

No complete published report is available for ProQR Therapeutics N.V. (PRQR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ProQR Therapeutics N.V. (PRQR)

Price

Financial snapshot

Fair-value bridge

Latest news · PRQR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PRQR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PRQR

Frequently asked questions